Prucalopride (Resolor®)

Assessment Status Rapid Review Complete
Drug Prucalopride
Brand Resolor®
Indication For the symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief.
Assessment Process
Rapid review commissioned 17/01/2011
Rapid review completed 29/03/2011
Rapid review outcome Full Pharmacoeconomic Evaluation not Recommended

Prucalopride (Resolor®) is to be reimbursed under the Community Drugs Schemes subject to conditions.